FXR-mediated regulation of eNOS expression in vascular endothelial cells (Q28572543)

2

1 reference

31 January 2017

Ramalinga Kuruba

3

1 reference

31 January 2017

Qiuhong Zhang

4

1 reference

31 January 2017

Xiang Gao

5

1 reference

31 January 2017

Fengtian He

6

1 reference

31 January 2017

Li-Ming Zhang

7

1 reference

31 January 2017

Bruce R. Pitt

8

1 reference

31 January 2017

Wen Xie

9

1 reference

31 January 2017

Song Li

Structure-function aspects in the nitric oxide synthases

10

1 reference

31 January 2017

1 January 2008

1 reference

31 January 2017

Cardiovascular Research

1 reference

31 January 2017

77

1 reference

31 January 2017

1

1 reference

31 January 2017

169–177

1 reference

31 January 2017

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

The regulation and pharmacology of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Signal transduction of eNOS activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-indepen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Upregulation of nitric oxide production in vascular endothelial cells by all-trans retinoic acid through the phosphoinositide 3-kinase/Akt pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Identification of a nuclear receptor for bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Endogenous bile acids are ligands for the nuclear receptor FXR/BAR

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Bile acids: natural ligands for an orphan nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Bile acid regulation of gene expression: roles of nuclear hormone receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Identification of a chemical tool for the orphan nuclear receptor FXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Expression and activation of the farnesoid X receptor in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Use of dominant negative nuclear receptors to study xenobiotic-inducible gene expression in primary cultured hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

CpG DNA-mediated immune response in pulmonary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016

The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVM016